Megalencephaly in the neonatal period as the initial manifestation of glutaric aciduria type I.
Iafolla
A K
AK
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710.
Kahler
S G
SG
D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy / Q000378:metabolism; D001921:Brain / Q000254:growth & development*; D002331:Carnitine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005977:Glutarates / Q000652:urine*; D050770:Glutaryl-CoA Dehydrogenase; D006801:Humans; D007231:Infant, Newborn; D010088:Oxidoreductases / Q000172:deficiency; D044925:Oxidoreductases Acting on CH-CH Group Donors; D012256:Riboflavin / Q000627:therapeutic use
D005977:Glutarates; D010088:Oxidoreductases; D044925:Oxidoreductases Acting on CH-CH Group Donors; D050770:Glutaryl-CoA Dehydrogenase; C035736:glutaric acid; D002331:Carnitine; D012256:Riboflavin